DFTX · Definium Therapeutics, Inc.
$45.08
+2.28 (+5.33%)
At close · Jul 21
Market Cap
$4.92B
Shares
109.07M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
72/100
Short interest 13.3% of shares — P94
Days to cover 2.1 — P45
Price vs VWAP +35.4% — P98
Short-volume trend -7.6% — P25
Short interest change +36.5% — P85
Worst FTD 0.15% of shares — P79
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 14,517,267 | 10,636,288 | +3,880,979 | 2.05 |
| 2026-06-15 | 10,636,288 | 9,425,925 | +1,210,363 | 4.44 |
| 2026-05-29 | 9,425,925 | 9,249,802 | +176,123 | 5.20 |
| 2026-05-15 | 9,249,802 | 9,356,720 | -106,918 | 6.63 |
| 2026-04-30 | 9,356,720 | 9,819,886 | -463,166 | 4.04 |
| 2026-04-15 | 9,819,886 | 15,129,638 | -5,309,752 | 5.85 |
| 2026-03-31 | 15,129,638 | 15,008,738 | +120,900 | 8.85 |
| 2026-03-13 | 15,008,738 | 19,343,010 | -4,334,272 | 8.28 |
| 2026-02-27 | 19,343,010 | 19,511,578 | -168,568 | 15.91 |
| 2026-02-13 | 19,511,578 | 17,667,835 | +1,843,743 | 13.53 |
| 2026-01-30 | 17,667,835 | 16,831,899 | +835,936 | 7.94 |
| 2026-01-15 | 16,831,899 | 15,054,621 | +1,777,278 | 7.34 |
Showing 1–12 of 12 settlements
Key facts
CIK
1813814
CUSIP
24477V105
13F (30d)
25 filings
25 filers
Visit website
Investor relations